Vivani Medical is a clinical stage developer of long-term pharmaceutical implants aimed at revolutionizing the treatment of patients with chronic diseases. Leveraging its proprietary NanoPortal™ platform, Vivani’s portfolio of tiny, subdermal drug implants address medication non-adherence by providing steady levels of medication over a target duration of six months or longer. Vivani is initially focused on developing a miniature, long-term GLP-1 implants for the treatment of obesity and chronic weight management: NPM-139 (semaglutide). In addition, the company is developing NPM-133, a semaglutide implant for the treatment of type 2 diabetes.
| Website | https://vivani.com/ |
| Revenue | $26.6 million |
| Employees | 35 (20 on RocketReach) |
| Address | 1350 S Loop Rd, Alameda, California 94502, US |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Chronic Disease Treatment, Drug Delivery, Drug Development, Preclinical Development, Pharmaceutical Research, Biomedical Technology, Controlled Release, Innovative Therapies, Nanotechnology, Medical Devices, Biotechnology, Medical Technology, Health Technology, Patient Care |
| Competitors | Cadbury plc., LINDT & SPRUENGLI AG-REG, Ghirardelli Chocolate Company, Alter Eco, Theo Chocolate, Taza Chocolate, Endangered Species Chocolate, Green & Black's, Scharffen Berger Chocolate Maker, LLC, DOVE Chocolate +20 more (view full list) |
Looking for a particular Vivani employee's phone or email?
The Vivani annual revenue was $26.6 million in 2026.
Adam Mendelsohn is the CEO of Vivani.
20 people are employed at Vivani.
Vivani is based in Alameda, California.